Literature DB >> 24306436

A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health.

Tom E Richardson1, Claire L O'Reilly, Timothy F Chen.   

Abstract

BACKGROUND: The importance of pharmacists in mental healthcare is starting to be recognised around the world. However few studies have focused on the evidence supporting pharmacist involvement in the inpatient mental healthcare setting. AIM: Evaluate types of outcomes achieved and level of evidence supporting clinical pharmacy services in inpatient mental health settings.
METHODS: Medline, PyscINFO and International Pharmaceutical Abstracts databases were searched from January 1990 to March 31 2013. Studies were included if in an inpatient setting, published in English, and reported an intervention provided by a pharmacist or involving a pharmacist with a pivotal role in an intervention team. Data were extracted according to sample population and size, study design and outline, country, role of the pharmacist in the study, and the main results of the study. The level of evidence for each study was assessed using Australia's National Health and Medical Research Council's hierarchy of clinical evidence and results were categorised as having economic, clinical and/or humanistic outcomes.
RESULTS: Eighteen articles met the inclusion criteria. A range of pharmaceutical services provided by pharmacists in inpatient mental healthcare were identified. These services highlight the role of pharmacists as reviewers of medication charts, laboratory results and medication prescribing and as educators of patients and other health care professionals. Six studies included a control or comparison group and had pre and post intervention measures. These comprised of three randomised control trials, one historical control study and two case series post and pre-post tests, corresponding to evidence levels of II, III-3 and IV respectively. Seven studies reported clinical outcomes, two economical and one humanistic outcomes. One study reported both clinical and economical outcomes. Seven studies focused on impact evaluation measures.
CONCLUSIONS: Pharmacists provide a variety of services and play a significant role in inpatient mental healthcare. However, the level of evidence supporting these services is limited and the type of outcomes achieved is narrow.

Entities:  

Mesh:

Year:  2013        PMID: 24306436     DOI: 10.1007/s11096-013-9900-y

Source DB:  PubMed          Journal:  Int J Clin Pharm


  30 in total

1.  The role of the ECHO model in outcomes research and clinical practice improvement.

Authors:  M J Gunter
Journal:  Am J Manag Care       Date:  1999-04       Impact factor: 2.229

2.  Randomized, controlled trials, observational studies, and the hierarchy of research designs.

Authors:  J Concato; N Shah; R I Horwitz
Journal:  N Engl J Med       Date:  2000-06-22       Impact factor: 91.245

3.  Clinical psychopharmacy consultations: acceptance of recommendations on an adult inpatient psychiatric unit.

Authors:  W A Morton; A R Mendenhall; P G Windsor; B Lydiard
Journal:  Hosp Pharm       Date:  1995-09

4.  Pharmacist interventions in an inpatient geriatric psychiatry unit.

Authors:  Christian Dolder; Becky Szymanski; Becky Symanski; Teri Wooton; Jonathan McKinsey
Journal:  Am J Health Syst Pharm       Date:  2008-10-01       Impact factor: 2.637

Review 5.  Clinical pharmacists and inpatient medical care: a systematic review.

Authors:  Peter J Kaboli; Angela B Hoth; Brad J McClimon; Jeffrey L Schnipper
Journal:  Arch Intern Med       Date:  2006-05-08

Review 6.  Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis.

Authors:  Maria Rubio-Valera; Antoni Serrano-Blanco; Jesús Magdalena-Belío; Ana Fernández; Javier García-Campayo; Marian March Pujol; Yolanda López del Hoyo
Journal:  Ann Pharmacother       Date:  2011-01-04       Impact factor: 3.154

7.  Impact of feedback from pharmacists in reducing antipsychotic polypharmacy in schizophrenia.

Authors:  Monica Hazra; Hiroyuki Uchida; Beth Sproule; Gary Remington; Takefumi Suzuki; David C Mamo
Journal:  Psychiatry Clin Neurosci       Date:  2011-12       Impact factor: 5.188

Review 8.  Evaluating the impact of pharmacists in mental health: a systematic review.

Authors:  Patrick R Finley; M Lynn Crismon; A John Rush
Journal:  Pharmacotherapy       Date:  2003-12       Impact factor: 4.705

9.  The impact of clinical pharmacy intervention in a psychiatric hospital.

Authors:  A Dorevitch; E Perl
Journal:  J Clin Pharm Ther       Date:  1996-02       Impact factor: 2.512

Review 10.  Screening for major diseases in community pharmacies: a systematic review.

Authors:  Abimbola Adebukola Ayorinde; Terry Porteous; Pawana Sharma
Journal:  Int J Pharm Pract       Date:  2013-05-20
View more
  13 in total

Review 1.  The need for community pharmacists in oncology outpatient care: a systematic review.

Authors:  Johannes Thoma; Romána Zelkó; Balázs Hankó
Journal:  Int J Clin Pharm       Date:  2016-04-07

2.  Balancing evidence and social responsibility when targeting clinical pharmacy services: the example of people with intellectual disabilities.

Authors:  J Simon Bell; Carl M Kirkpatrick; Christopher P Alderman
Journal:  Int J Clin Pharm       Date:  2015-04-24

3.  Drug-related problems and the clinical role of pharmacists in inpatient mental health: an insight into practice in Australia.

Authors:  Tom E Richardson; Claire L O'Reilly; Timothy F Chen
Journal:  Int J Clin Pharm       Date:  2014-08-10

Review 4.  Pharmacists' medicines-related interventions for people with intellectual disabilities: a narrative review.

Authors:  Máire O'Dwyer; Arijana Meštrović; Martin Henman
Journal:  Int J Clin Pharm       Date:  2015-04-24

5.  Impact of pharmacists on outcomes for patients with psychiatric or neurologic disorders.

Authors:  Amy Werremeyer; Jolene Bostwick; Carla Cobb; Tera D Moore; Susie H Park; Cristofer Price; Jerry McKee
Journal:  Ment Health Clin       Date:  2020-11-05

6.  Pharmaceutical care in a long-stay psychiatric hospital.

Authors:  Ivana M Ilickovic; Slobodan M Jankovic; Aleksandar Tomcuk; Jovo Djedovic
Journal:  Eur J Hosp Pharm       Date:  2015-11-27

Review 7.  New roles for pharmacists in community mental health care: a narrative review.

Authors:  Maria Rubio-Valera; Timothy F Chen; Claire L O'Reilly
Journal:  Int J Environ Res Public Health       Date:  2014-10-21       Impact factor: 3.390

8.  Pharmacists' roles in supporting people living with severe and persistent mental illness: a systematic review protocol.

Authors:  Sarira El-Den; Sara S McMillan; Amanda J Wheeler; Ricki Ng; Helena Roennfeldt; Claire L O'Reilly
Journal:  BMJ Open       Date:  2020-07-13       Impact factor: 2.692

9.  Innovative Partnership between a Rural Mental Health Center and Community Pharmacy: Integration of a Mental Health Pharmacist.

Authors:  ShuYing Ng; Robert Buckner Jones; Laura Schwartzwald; Meena Murugappan; Amy Pittenger; Kevin Edwards; Randall Seifert
Journal:  Innov Pharm       Date:  2019-08-31

10.  A Case of Schizophrenia in a Young Male Adult with no History of Substance Abuse: Impact of Clinical Pharmacists' Interventions on Patient Outcome.

Authors:  Mercy N A Opare-Addo; Josephine Mensah; Grace Owusu Aboagye
Journal:  Case Rep Psychiatry       Date:  2020-02-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.